Vascular Intervention Program: a strategy of medication management for cardiovascular risk in people with type 2 diabetes

Not Applicable

Completed

• Conditions: Type 2 diabetes mellitus; Nutritional, Metabolic, Endocrine; Diabetes mellitus type 2

• Registration Number: ISRCTN97121854
• Lead Sponsor: Canadian Diabetes Association

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-19
• Last Update Posted: 3 July 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Patients with type 2 diabetes, who are not considered for urgent assessment by the Regional Diabetes Program (i.e. those with A1c <0.08, blood pressure <220/120, or triglycerides <15 mmol/l)

Exclusion Criteria

1. Subjects currently followed in specialty clinics for management of hypertension, hyperlipidemia, or diabetes
2. Those who decline an invitation to participate
3. Those who are cognitively impaired (i.e. unable to give informed consent)
3. Those who are not responsible for their own medication consumption
4. Those who are unable to communicate in English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of subjects achieving a 10% reduction in systolic blood pressure from baseline